STOCK TITAN

HIMS & HERS (HIMS) — JPMorgan reports 3.881M shares, 1.7% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

JPMorgan Chase & Co. filed Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 3,881,790 shares of Class A common stock of HIMS & HERS HEALTH, INC., representing 1.7% of the class as reported.

The filing lists specific voting and dispositive powers: sole power to vote 3,399,965, shared power to vote 13, sole power to dispose 3,879,553, and shared power to dispose 2,145. It identifies subsidiaries including J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC. The form is signed by a JPMorgan vice president on 03/05/2026.

Positive

  • None.

Negative

  • None.

Insights

Large custodian reports a 1.7% stake in HIMS, showing voting and dispositive breakdowns.

JPMorgan Chase reports beneficial ownership of 3,881,790 shares and discloses both voting and dispositive powers, with 3,399,965 shares subject to sole voting power and 3,879,553 shares subject to sole dispositive power. The filing names multiple affiliated entities that hold or control the position.

The filing is an Amendment No. 1 to a Schedule 13G/A, indicating a passive institutional reporting posture under the securities rules; timing and trading intent are not stated in the excerpt.

The report clarifies beneficial control lines among JPMorgan affiliates, useful for shareholder voting analysis.

The schedule itemizes who holds voting versus dispositive authority, which matters when mapping which JPMorgan entities may exercise voting rights at shareholder meetings. Subsidiaries named include J.P. Morgan Trust Company of Delaware and J.P. Morgan Securities LLC.

Any governance impact depends on whether these shares are voted; the filing itself does not state voting intentions or arrangements.






02/27/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



JPMORGAN CHASE & CO.
Signature:Rachel Tsvaygoft
Name/Title:Vice President
Date:03/05/2026

FAQ

What stake did JPMorgan report in HIMS (HIMS)?

JPMorgan reported beneficial ownership of 3,881,790 shares, equal to 1.7% of HIMS Class A common stock. The filing is Amendment No. 1 to a Schedule 13G/A and lists the detailed voting and dispositive power breakdowns.

Who at JPMorgan holds voting or dispositive power over the HIMS shares?

The filing shows sole voting power for 3,399,965 shares and sole dispositive power for 3,879,553 shares. It also reports small shared voting and dispositive holdings of 13 and 2,145 shares respectively.

Which JPMorgan affiliates are named in the HIMS ownership filing?

Named affiliates include J.P. Morgan Trust Company of Delaware, J.P. Morgan Securities LLC, JPMorgan Chase Bank, N.A., J.P. Morgan Investment Management Inc., and 55I, LLC as listed in the schedule.

Does the Schedule 13G/A state JPMorgan's intent to vote or sell HIMS shares?

The filing lists voting and dispositive powers but does not state any explicit intent to vote or sell. It is an amendment to a passive Schedule 13G/A and does not disclose trading intentions in the excerpt.

When was the JPMorgan Schedule 13G/A amendment signed?

The schedule is signed by Rachel Tsvaygoft, Vice President, on 03/05/2026. The header also references 02/27/2026 within the filing content.
Hims & Hers Health Inc

NYSE:HIMS

View HIMS Stock Overview

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

3.62B
203.81M
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO